A Phase 1/2A Single Center Trial of Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Using the Drug LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs EB 101 (Primary)
- Indications Epidermolysis bullosa
- Focus Proof of concept; Therapeutic Use
- 06 Jun 2018 According to an Abeona therapeutics media release, data from this study will be presented at the Jefferies 2018 Global Healthcare Conference.
- 17 May 2018 Primary endpoint Percentage surface area of wound healing has been met, according to the Abeona Therapeutics media release.
- 17 May 2018 Results presented in the Abeona Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History